nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—EPHA2—pulmonary artery—idiopathic pulmonary fibrosis	0.031	0.0575	CbGeAlD
Crizotinib—ROS1—respiratory system—idiopathic pulmonary fibrosis	0.0266	0.0493	CbGeAlD
Crizotinib—ROS1—lung—idiopathic pulmonary fibrosis	0.0141	0.0262	CbGeAlD
Crizotinib—NEK9—respiratory system—idiopathic pulmonary fibrosis	0.0132	0.0245	CbGeAlD
Crizotinib—PRKD1—respiratory system—idiopathic pulmonary fibrosis	0.012	0.0223	CbGeAlD
Crizotinib—TXK—respiratory system—idiopathic pulmonary fibrosis	0.0107	0.0198	CbGeAlD
Crizotinib—MET—respiratory system—idiopathic pulmonary fibrosis	0.01	0.0186	CbGeAlD
Crizotinib—CDK7—respiratory system—idiopathic pulmonary fibrosis	0.00969	0.018	CbGeAlD
Crizotinib—PLK4—respiratory system—idiopathic pulmonary fibrosis	0.00873	0.0162	CbGeAlD
Crizotinib—ALK—respiratory system—idiopathic pulmonary fibrosis	0.0082	0.0152	CbGeAlD
Crizotinib—MAP3K19—respiratory system—idiopathic pulmonary fibrosis	0.00803	0.0149	CbGeAlD
Crizotinib—IGF1R—respiratory system—idiopathic pulmonary fibrosis	0.00787	0.0146	CbGeAlD
Crizotinib—TIE1—respiratory system—idiopathic pulmonary fibrosis	0.00766	0.0142	CbGeAlD
Crizotinib—LIMK2—respiratory system—idiopathic pulmonary fibrosis	0.00704	0.0131	CbGeAlD
Crizotinib—NEK9—lung—idiopathic pulmonary fibrosis	0.00702	0.013	CbGeAlD
Crizotinib—FLT3—respiratory system—idiopathic pulmonary fibrosis	0.00697	0.0129	CbGeAlD
Crizotinib—ACVR1—respiratory system—idiopathic pulmonary fibrosis	0.00697	0.0129	CbGeAlD
Crizotinib—PRKD1—lung—idiopathic pulmonary fibrosis	0.0064	0.0119	CbGeAlD
Crizotinib—PTK2B—respiratory system—idiopathic pulmonary fibrosis	0.00635	0.0118	CbGeAlD
Crizotinib—PRKD3—lung—idiopathic pulmonary fibrosis	0.00615	0.0114	CbGeAlD
Crizotinib—DSTYK—lung—idiopathic pulmonary fibrosis	0.006	0.0111	CbGeAlD
Crizotinib—LTK—lung—idiopathic pulmonary fibrosis	0.00587	0.0109	CbGeAlD
Crizotinib—CASK—lung—idiopathic pulmonary fibrosis	0.00587	0.0109	CbGeAlD
Crizotinib—TBK1—respiratory system—idiopathic pulmonary fibrosis	0.00584	0.0108	CbGeAlD
Crizotinib—PTK2—respiratory system—idiopathic pulmonary fibrosis	0.00584	0.0108	CbGeAlD
Crizotinib—TYK2—respiratory system—idiopathic pulmonary fibrosis	0.00581	0.0108	CbGeAlD
Crizotinib—MAPK7—lung—idiopathic pulmonary fibrosis	0.00568	0.0105	CbGeAlD
Crizotinib—TXK—lung—idiopathic pulmonary fibrosis	0.00568	0.0105	CbGeAlD
Crizotinib—FES—lung—idiopathic pulmonary fibrosis	0.00563	0.0104	CbGeAlD
Crizotinib—RPS6KB1—respiratory system—idiopathic pulmonary fibrosis	0.00562	0.0104	CbGeAlD
Crizotinib—FGR—respiratory system—idiopathic pulmonary fibrosis	0.00559	0.0104	CbGeAlD
Crizotinib—AXL—respiratory system—idiopathic pulmonary fibrosis	0.00557	0.0103	CbGeAlD
Crizotinib—MET—lung—idiopathic pulmonary fibrosis	0.00532	0.00986	CbGeAlD
Crizotinib—EPHB4—respiratory system—idiopathic pulmonary fibrosis	0.00532	0.00986	CbGeAlD
Crizotinib—JAK2—respiratory system—idiopathic pulmonary fibrosis	0.00528	0.00979	CbGeAlD
Crizotinib—EPHA2—respiratory system—idiopathic pulmonary fibrosis	0.00522	0.00968	CbGeAlD
Crizotinib—CDK7—lung—idiopathic pulmonary fibrosis	0.00515	0.00954	CbGeAlD
Crizotinib—TAOK2—lung—idiopathic pulmonary fibrosis	0.0051	0.00947	CbGeAlD
Crizotinib—TEK—respiratory system—idiopathic pulmonary fibrosis	0.00509	0.00944	CbGeAlD
Crizotinib—EPHA3—lung—idiopathic pulmonary fibrosis	0.00492	0.00912	CbGeAlD
Crizotinib—ACVR1B—lung—idiopathic pulmonary fibrosis	0.00492	0.00912	CbGeAlD
Crizotinib—YES1—respiratory system—idiopathic pulmonary fibrosis	0.0047	0.00872	CbGeAlD
Crizotinib—JAK3—lung—idiopathic pulmonary fibrosis	0.00469	0.0087	CbGeAlD
Crizotinib—DCLK1—lung—idiopathic pulmonary fibrosis	0.00466	0.00864	CbGeAlD
Crizotinib—STK10—respiratory system—idiopathic pulmonary fibrosis	0.00466	0.00864	CbGeAlD
Crizotinib—TAOK3—respiratory system—idiopathic pulmonary fibrosis	0.00464	0.00861	CbGeAlD
Crizotinib—PLK4—lung—idiopathic pulmonary fibrosis	0.00463	0.00859	CbGeAlD
Crizotinib—STK4—lung—idiopathic pulmonary fibrosis	0.0046	0.00854	CbGeAlD
Crizotinib—SRC—respiratory system—idiopathic pulmonary fibrosis	0.00452	0.00839	CbGeAlD
Crizotinib—FER—lung—idiopathic pulmonary fibrosis	0.00435	0.00807	CbGeAlD
Crizotinib—ALK—lung—idiopathic pulmonary fibrosis	0.00435	0.00807	CbGeAlD
Crizotinib—TNK1—lung—idiopathic pulmonary fibrosis	0.00431	0.00799	CbGeAlD
Crizotinib—BMPR1B—lung—idiopathic pulmonary fibrosis	0.00426	0.00791	CbGeAlD
Crizotinib—MAP4K1—lung—idiopathic pulmonary fibrosis	0.00426	0.00791	CbGeAlD
Crizotinib—MAP3K19—lung—idiopathic pulmonary fibrosis	0.00426	0.00791	CbGeAlD
Crizotinib—IGF1R—lung—idiopathic pulmonary fibrosis	0.00418	0.00775	CbGeAlD
Crizotinib—TNK2—lung—idiopathic pulmonary fibrosis	0.00418	0.00775	CbGeAlD
Crizotinib—MAP4K2—lung—idiopathic pulmonary fibrosis	0.00412	0.00764	CbGeAlD
Crizotinib—STK3—lung—idiopathic pulmonary fibrosis	0.00407	0.00754	CbGeAlD
Crizotinib—TIE1—lung—idiopathic pulmonary fibrosis	0.00407	0.00754	CbGeAlD
Crizotinib—CSF1R—respiratory system—idiopathic pulmonary fibrosis	0.00406	0.00753	CbGeAlD
Crizotinib—AURKA—lung—idiopathic pulmonary fibrosis	0.00396	0.00735	CbGeAlD
Crizotinib—TESK1—lung—idiopathic pulmonary fibrosis	0.00393	0.00729	CbGeAlD
Crizotinib—MERTK—lung—idiopathic pulmonary fibrosis	0.00382	0.00709	CbGeAlD
Crizotinib—LIMK2—lung—idiopathic pulmonary fibrosis	0.00374	0.00693	CbGeAlD
Crizotinib—NUAK2—lung—idiopathic pulmonary fibrosis	0.00373	0.00691	CbGeAlD
Crizotinib—MAP3K12—lung—idiopathic pulmonary fibrosis	0.0037	0.00686	CbGeAlD
Crizotinib—FLT3—lung—idiopathic pulmonary fibrosis	0.0037	0.00686	CbGeAlD
Crizotinib—ACVR1—lung—idiopathic pulmonary fibrosis	0.0037	0.00686	CbGeAlD
Crizotinib—STK35—lung—idiopathic pulmonary fibrosis	0.00363	0.00672	CbGeAlD
Crizotinib—ABL2—lung—idiopathic pulmonary fibrosis	0.00353	0.00655	CbGeAlD
Crizotinib—BMP2K—lung—idiopathic pulmonary fibrosis	0.00349	0.00647	CbGeAlD
Crizotinib—PTK2B—lung—idiopathic pulmonary fibrosis	0.00337	0.00625	CbGeAlD
Crizotinib—RIPK2—lung—idiopathic pulmonary fibrosis	0.00334	0.0062	CbGeAlD
Crizotinib—EPHA4—lung—idiopathic pulmonary fibrosis	0.00323	0.00599	CbGeAlD
Crizotinib—ABL1—respiratory system—idiopathic pulmonary fibrosis	0.00321	0.00595	CbGeAlD
Crizotinib—MAP3K2—lung—idiopathic pulmonary fibrosis	0.00317	0.00588	CbGeAlD
Crizotinib—PTK2—lung—idiopathic pulmonary fibrosis	0.0031	0.00575	CbGeAlD
Crizotinib—TBK1—lung—idiopathic pulmonary fibrosis	0.0031	0.00575	CbGeAlD
Crizotinib—TYK2—lung—idiopathic pulmonary fibrosis	0.00308	0.00572	CbGeAlD
Crizotinib—IRAK1—lung—idiopathic pulmonary fibrosis	0.00304	0.00564	CbGeAlD
Crizotinib—RPS6KB1—lung—idiopathic pulmonary fibrosis	0.00299	0.00554	CbGeAlD
Crizotinib—FGR—lung—idiopathic pulmonary fibrosis	0.00297	0.0055	CbGeAlD
Crizotinib—LCK—lung—idiopathic pulmonary fibrosis	0.00297	0.0055	CbGeAlD
Crizotinib—AXL—lung—idiopathic pulmonary fibrosis	0.00296	0.00548	CbGeAlD
Crizotinib—SLK—lung—idiopathic pulmonary fibrosis	0.00284	0.00527	CbGeAlD
Crizotinib—EPHB4—lung—idiopathic pulmonary fibrosis	0.00282	0.00524	CbGeAlD
Crizotinib—JAK2—lung—idiopathic pulmonary fibrosis	0.0028	0.0052	CbGeAlD
Crizotinib—EPHA2—lung—idiopathic pulmonary fibrosis	0.00277	0.00514	CbGeAlD
Crizotinib—MAP4K5—lung—idiopathic pulmonary fibrosis	0.0027	0.00501	CbGeAlD
Crizotinib—TEK—lung—idiopathic pulmonary fibrosis	0.0027	0.00501	CbGeAlD
Crizotinib—MAP3K3—lung—idiopathic pulmonary fibrosis	0.0027	0.00501	CbGeAlD
Crizotinib—EPHB6—lung—idiopathic pulmonary fibrosis	0.00258	0.00479	CbGeAlD
Crizotinib—YES1—lung—idiopathic pulmonary fibrosis	0.0025	0.00463	CbGeAlD
Crizotinib—STK10—lung—idiopathic pulmonary fibrosis	0.00247	0.00459	CbGeAlD
Crizotinib—TAOK3—lung—idiopathic pulmonary fibrosis	0.00246	0.00457	CbGeAlD
Crizotinib—SRC—lung—idiopathic pulmonary fibrosis	0.0024	0.00445	CbGeAlD
Crizotinib—CSF1R—lung—idiopathic pulmonary fibrosis	0.00216	0.004	CbGeAlD
Crizotinib—CYP3A5—respiratory system—idiopathic pulmonary fibrosis	0.00188	0.00348	CbGeAlD
Crizotinib—ABL1—lung—idiopathic pulmonary fibrosis	0.0017	0.00316	CbGeAlD
Crizotinib—ABCB1—respiratory system—idiopathic pulmonary fibrosis	0.000998	0.00185	CbGeAlD
Crizotinib—CYP3A5—lung—idiopathic pulmonary fibrosis	0.000998	0.00185	CbGeAlD
Crizotinib—ABCB1—lung—idiopathic pulmonary fibrosis	0.00053	0.000983	CbGeAlD
Crizotinib—PTK2B—TCR Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000406	0.000882	CbGpPWpGaD
Crizotinib—ABL2—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000406	0.000881	CbGpPWpGaD
Crizotinib—EPHA3—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000406	0.000881	CbGpPWpGaD
Crizotinib—EPHA5—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000406	0.000881	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000396	0.00086	CbGpPWpGaD
Crizotinib—JAK2—Interleukin-11 Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000395	0.000857	CbGpPWpGaD
Crizotinib—EPHA8—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000391	0.00085	CbGpPWpGaD
Crizotinib—LIMK2—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000387	0.00084	CbGpPWpGaD
Crizotinib—EPHA4—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000387	0.00084	CbGpPWpGaD
Crizotinib—EPHB4—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000387	0.00084	CbGpPWpGaD
Crizotinib—LYN—IL-3 Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000387	0.00084	CbGpPWpGaD
Crizotinib—PTK2—Primary Focal Segmental Glomerulosclerosis FSGS—TGFB1—idiopathic pulmonary fibrosis	0.000387	0.00084	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000384	0.000834	CbGpPWpGaD
Crizotinib—MAPK7—MAPK Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.00038	0.000825	CbGpPWpGaD
Crizotinib—LIMK1—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000379	0.000822	CbGpPWpGaD
Crizotinib—EPHB6—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000364	0.00079	CbGpPWpGaD
Crizotinib—JAK2—IL-3 Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000362	0.000786	CbGpPWpGaD
Crizotinib—SRC—Senescence and Autophagy in Cancer—SMAD3—idiopathic pulmonary fibrosis	0.00036	0.000782	CbGpPWpGaD
Crizotinib—SRC—Syndecan-2-mediated signaling events—TGFB1—idiopathic pulmonary fibrosis	0.000359	0.00078	CbGpPWpGaD
Crizotinib—CASK—Extracellular matrix organization—TGFB1—idiopathic pulmonary fibrosis	0.000357	0.000775	CbGpPWpGaD
Crizotinib—EPHA2—NRF2 pathway—TGFB1—idiopathic pulmonary fibrosis	0.000354	0.000769	CbGpPWpGaD
Crizotinib—PTK2—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000353	0.000767	CbGpPWpGaD
Crizotinib—YES1—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000349	0.000757	CbGpPWpGaD
Crizotinib—MAP3K2—MAPK Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000346	0.000751	CbGpPWpGaD
Crizotinib—MAP4K1—MAPK Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000346	0.000751	CbGpPWpGaD
Crizotinib—LCK—Cell surface interactions at the vascular wall—FN1—idiopathic pulmonary fibrosis	0.000344	0.000747	CbGpPWpGaD
Crizotinib—MAPK7—Integrated Pancreatic Cancer Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000343	0.000745	CbGpPWpGaD
Crizotinib—EPHA6—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000342	0.000743	CbGpPWpGaD
Crizotinib—PTK2—Focal Adhesion—FN1—idiopathic pulmonary fibrosis	0.000339	0.000735	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000331	0.000718	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.00033	0.000716	CbGpPWpGaD
Crizotinib—MERTK—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	0.000329	0.000715	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000325	0.000706	CbGpPWpGaD
Crizotinib—TYK2—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000321	0.000697	CbGpPWpGaD
Crizotinib—PTK2—Corticotropin-releasing hormone—TGFB1—idiopathic pulmonary fibrosis	0.000318	0.00069	CbGpPWpGaD
Crizotinib—SRC—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—idiopathic pulmonary fibrosis	0.000318	0.00069	CbGpPWpGaD
Crizotinib—TEK—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.000316	0.000685	CbGpPWpGaD
Crizotinib—EPHA2—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000316	0.000685	CbGpPWpGaD
Crizotinib—EPHA7—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000316	0.000685	CbGpPWpGaD
Crizotinib—SRC—Senescence and Autophagy in Cancer—PLAU—idiopathic pulmonary fibrosis	0.000313	0.000678	CbGpPWpGaD
Crizotinib—ABCB1—HIF-1-alpha transcription factor network—SMAD3—idiopathic pulmonary fibrosis	0.000309	0.000671	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000308	0.000669	CbGpPWpGaD
Crizotinib—SRC—Interleukin-11 Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000306	0.000664	CbGpPWpGaD
Crizotinib—SRC—Cell surface interactions at the vascular wall—FN1—idiopathic pulmonary fibrosis	0.000305	0.000661	CbGpPWpGaD
Crizotinib—PTK2—Platelet activation, signaling and aggregation—FN1—idiopathic pulmonary fibrosis	0.0003	0.000652	CbGpPWpGaD
Crizotinib—SRC—TGF-beta Signaling Pathway—SMAD3—idiopathic pulmonary fibrosis	0.0003	0.000652	CbGpPWpGaD
Crizotinib—AURKA—Cell Cycle—TERT—idiopathic pulmonary fibrosis	0.0003	0.000651	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000299	0.00065	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—ATP11A—idiopathic pulmonary fibrosis	0.000298	0.000647	CbGpPWpGaD
Crizotinib—ABL1—Regulation of Telomerase—TGFB1—idiopathic pulmonary fibrosis	0.000296	0.000643	CbGpPWpGaD
Crizotinib—SRC—Aryl Hydrocarbon Receptor Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000295	0.000641	CbGpPWpGaD
Crizotinib—TEK—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000293	0.000637	CbGpPWpGaD
Crizotinib—SRC—Senescence and Autophagy in Cancer—FN1—idiopathic pulmonary fibrosis	0.000291	0.000631	CbGpPWpGaD
Crizotinib—PLK4—Cell Cycle—TERT—idiopathic pulmonary fibrosis	0.000288	0.000624	CbGpPWpGaD
Crizotinib—ABCB1—HIF-1-alpha transcription factor network—TERT—idiopathic pulmonary fibrosis	0.000283	0.000614	CbGpPWpGaD
Crizotinib—SRC—IL-3 Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000281	0.00061	CbGpPWpGaD
Crizotinib—SRC—TGF-beta Signaling Pathway—TERT—idiopathic pulmonary fibrosis	0.000275	0.000597	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000264	0.000572	CbGpPWpGaD
Crizotinib—LYN—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.00026	0.000564	CbGpPWpGaD
Crizotinib—ABL1—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000259	0.000562	CbGpPWpGaD
Crizotinib—JAK2—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000243	0.000528	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000242	0.000526	CbGpPWpGaD
Crizotinib—SRC—TGF-beta Signaling Pathway—FN1—idiopathic pulmonary fibrosis	0.000242	0.000525	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000241	0.000524	CbGpPWpGaD
Crizotinib—ACVR1B—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000239	0.000519	CbGpPWpGaD
Crizotinib—PTK2—TGF-beta Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000238	0.000517	CbGpPWpGaD
Crizotinib—JAK3—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.000238	0.000517	CbGpPWpGaD
Crizotinib—NTRK1—MAPK Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000236	0.000512	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000227	0.000493	CbGpPWpGaD
Crizotinib—JAK3—Platelet activation, signaling and aggregation—TGFB1—idiopathic pulmonary fibrosis	0.000225	0.000489	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000224	0.000486	CbGpPWpGaD
Crizotinib—CDK7—Cell Cycle—TERT—idiopathic pulmonary fibrosis	0.000222	0.000481	CbGpPWpGaD
Crizotinib—JAK3—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000221	0.00048	CbGpPWpGaD
Crizotinib—LYN—Platelet activation, signaling and aggregation—FN1—idiopathic pulmonary fibrosis	0.000221	0.000479	CbGpPWpGaD
Crizotinib—ABL1—Cell Cycle—TGFB1—idiopathic pulmonary fibrosis	0.000214	0.000465	CbGpPWpGaD
Crizotinib—LCK—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000213	0.000462	CbGpPWpGaD
Crizotinib—NTRK1—Integrated Pancreatic Cancer Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000213	0.000462	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000212	0.000461	CbGpPWpGaD
Crizotinib—MET—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000207	0.00045	CbGpPWpGaD
Crizotinib—JAK2—Platelet activation, signaling and aggregation—FN1—idiopathic pulmonary fibrosis	0.000207	0.000448	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000205	0.000445	CbGpPWpGaD
Crizotinib—FGR—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.000203	0.000441	CbGpPWpGaD
Crizotinib—ABL1—DNA Damage Response (only ATM dependent)—TGFB1—idiopathic pulmonary fibrosis	0.000203	0.000441	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000199	0.000431	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000196	0.000425	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000193	0.000419	CbGpPWpGaD
Crizotinib—FGR—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000189	0.00041	CbGpPWpGaD
Crizotinib—SRC—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000189	0.000409	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000188	0.000408	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000188	0.000408	CbGpPWpGaD
Crizotinib—FES—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000181	0.000393	CbGpPWpGaD
Crizotinib—LCK—Platelet activation, signaling and aggregation—FN1—idiopathic pulmonary fibrosis	0.000181	0.000393	CbGpPWpGaD
Crizotinib—SRC—Focal Adhesion—FN1—idiopathic pulmonary fibrosis	0.000181	0.000392	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000181	0.000392	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000178	0.000386	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000178	0.000386	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000176	0.000382	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000172	0.000373	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000172	0.000373	CbGpPWpGaD
Crizotinib—EPHA5—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000172	0.000373	CbGpPWpGaD
Crizotinib—ABL2—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000172	0.000373	CbGpPWpGaD
Crizotinib—EPHA3—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000172	0.000373	CbGpPWpGaD
Crizotinib—PTK2—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.000166	0.000361	CbGpPWpGaD
Crizotinib—EPHA8—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000166	0.00036	CbGpPWpGaD
Crizotinib—YES1—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.000164	0.000356	CbGpPWpGaD
Crizotinib—LIMK2—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000164	0.000356	CbGpPWpGaD
Crizotinib—EPHA4—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000164	0.000356	CbGpPWpGaD
Crizotinib—EPHB4—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000164	0.000356	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000163	0.000354	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000163	0.000353	CbGpPWpGaD
Crizotinib—LIMK1—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.00016	0.000348	CbGpPWpGaD
Crizotinib—SRC—Platelet activation, signaling and aggregation—FN1—idiopathic pulmonary fibrosis	0.00016	0.000348	CbGpPWpGaD
Crizotinib—PTK2—Platelet activation, signaling and aggregation—TGFB1—idiopathic pulmonary fibrosis	0.000158	0.000342	CbGpPWpGaD
Crizotinib—PTK2—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000155	0.000336	CbGpPWpGaD
Crizotinib—TEK—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	0.000154	0.000335	CbGpPWpGaD
Crizotinib—EPHB6—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000154	0.000334	CbGpPWpGaD
Crizotinib—SRC—Senescence and Autophagy in Cancer—TGFB1—idiopathic pulmonary fibrosis	0.000153	0.000331	CbGpPWpGaD
Crizotinib—YES1—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000153	0.000331	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000151	0.000329	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000151	0.000329	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000149	0.000324	CbGpPWpGaD
Crizotinib—EPHA6—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000145	0.000314	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000144	0.000312	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000144	0.000312	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000143	0.000311	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000142	0.000309	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000135	0.000292	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—SMAD3—idiopathic pulmonary fibrosis	0.000134	0.00029	CbGpPWpGaD
Crizotinib—EPHA2—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000134	0.00029	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000131	0.000285	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.00013	0.000283	CbGpPWpGaD
Crizotinib—ABL1—Integrated Pancreatic Cancer Pathway—TGFB1—idiopathic pulmonary fibrosis	0.00013	0.000282	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000129	0.000279	CbGpPWpGaD
Crizotinib—SRC—TGF-beta Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000127	0.000276	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000126	0.000273	CbGpPWpGaD
Crizotinib—CDK7—Disease—SMAD3—idiopathic pulmonary fibrosis	0.000124	0.00027	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.000122	0.000266	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.000122	0.000264	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000118	0.000256	CbGpPWpGaD
Crizotinib—JAK3—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	0.000116	0.000252	CbGpPWpGaD
Crizotinib—LYN—Platelet activation, signaling and aggregation—TGFB1—idiopathic pulmonary fibrosis	0.000116	0.000252	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000115	0.00025	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000115	0.000249	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.000115	0.000249	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000114	0.000247	CbGpPWpGaD
Crizotinib—CDK7—Disease—TERT—idiopathic pulmonary fibrosis	0.000114	0.000247	CbGpPWpGaD
Crizotinib—ABCB1—Allograft Rejection—TGFB1—idiopathic pulmonary fibrosis	0.000113	0.000246	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000113	0.000246	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	0.000112	0.000242	CbGpPWpGaD
Crizotinib—JAK2—Platelet activation, signaling and aggregation—TGFB1—idiopathic pulmonary fibrosis	0.000109	0.000236	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000106	0.000231	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000104	0.000227	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000104	0.000225	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000102	0.00022	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.0001	0.000218	CbGpPWpGaD
Crizotinib—FGR—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	9.93e-05	0.000216	CbGpPWpGaD
Crizotinib—LCK—Platelet activation, signaling and aggregation—TGFB1—idiopathic pulmonary fibrosis	9.51e-05	0.000206	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	9.49e-05	0.000206	CbGpPWpGaD
Crizotinib—SRC—Integrated Pancreatic Cancer Pathway—TGFB1—idiopathic pulmonary fibrosis	9.46e-05	0.000205	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—FN1—idiopathic pulmonary fibrosis	9.33e-05	0.000202	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	9.31e-05	0.000202	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—PLAU—idiopathic pulmonary fibrosis	8.88e-05	0.000193	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	8.52e-05	0.000185	CbGpPWpGaD
Crizotinib—TYK2—Disease—SMAD3—idiopathic pulmonary fibrosis	8.44e-05	0.000183	CbGpPWpGaD
Crizotinib—SRC—Platelet activation, signaling and aggregation—TGFB1—idiopathic pulmonary fibrosis	8.42e-05	0.000183	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	8.29e-05	0.00018	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	8.29e-05	0.00018	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—FN1—idiopathic pulmonary fibrosis	8.26e-05	0.000179	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	8.17e-05	0.000177	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	8.17e-05	0.000177	CbGpPWpGaD
Crizotinib—PTK2—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	8.13e-05	0.000176	CbGpPWpGaD
Crizotinib—YES1—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	8.02e-05	0.000174	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	7.95e-05	0.000173	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	7.95e-05	0.000173	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	7.82e-05	0.00017	CbGpPWpGaD
Crizotinib—TYK2—Disease—TERT—idiopathic pulmonary fibrosis	7.73e-05	0.000168	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	7.59e-05	0.000165	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	7.59e-05	0.000165	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	7.54e-05	0.000164	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	7.52e-05	0.000163	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	7.5e-05	0.000163	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	7.48e-05	0.000162	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	7.16e-05	0.000155	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	6.95e-05	0.000151	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	6.89e-05	0.00015	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	6.69e-05	0.000145	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	6.59e-05	0.000143	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	6.51e-05	0.000141	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	6.42e-05	0.000139	CbGpPWpGaD
Crizotinib—JAK2—Disease—SMAD3—idiopathic pulmonary fibrosis	6.4e-05	0.000139	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	6.31e-05	0.000137	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	6.12e-05	0.000133	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	6.09e-05	0.000132	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	6.09e-05	0.000132	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	6.07e-05	0.000132	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	6.03e-05	0.000131	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	5.98e-05	0.00013	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	5.96e-05	0.000129	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	5.95e-05	0.000129	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	5.91e-05	0.000128	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	5.88e-05	0.000128	CbGpPWpGaD
Crizotinib—JAK2—Disease—TERT—idiopathic pulmonary fibrosis	5.86e-05	0.000127	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	5.7e-05	0.000124	CbGpPWpGaD
Crizotinib—LCK—Disease—SMAD3—idiopathic pulmonary fibrosis	5.6e-05	0.000122	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—idiopathic pulmonary fibrosis	5.6e-05	0.000121	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	5.59e-05	0.000121	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	5.57e-05	0.000121	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	5.45e-05	0.000118	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	5.41e-05	0.000117	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	5.33e-05	0.000116	CbGpPWpGaD
Crizotinib—CDK7—Disease—TGFB1—idiopathic pulmonary fibrosis	5.26e-05	0.000114	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	5.25e-05	0.000114	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	5.17e-05	0.000112	CbGpPWpGaD
Crizotinib—LCK—Disease—TERT—idiopathic pulmonary fibrosis	5.13e-05	0.000111	CbGpPWpGaD
Crizotinib—SRC—Disease—SMAD3—idiopathic pulmonary fibrosis	4.96e-05	0.000108	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	4.91e-05	0.000107	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	4.9e-05	0.000106	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	4.79e-05	0.000104	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	4.76e-05	0.000103	CbGpPWpGaD
Crizotinib—SRC—Disease—TERT—idiopathic pulmonary fibrosis	4.54e-05	9.86e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	4.48e-05	9.72e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	4.42e-05	9.6e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	4.38e-05	9.51e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	4.34e-05	9.42e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	4.1e-05	8.9e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	3.94e-05	8.55e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	3.92e-05	8.52e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	3.86e-05	8.37e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	3.61e-05	7.84e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	3.59e-05	7.8e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—TGFB1—idiopathic pulmonary fibrosis	3.57e-05	7.76e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	3.51e-05	7.62e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	3.47e-05	7.54e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	3.46e-05	7.51e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	3.31e-05	7.19e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	3.21e-05	6.97e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	3.18e-05	6.9e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	3.16e-05	6.86e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	2.8e-05	6.08e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	2.76e-05	5.98e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	2.72e-05	5.9e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—TGFB1—idiopathic pulmonary fibrosis	2.71e-05	5.88e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	2.58e-05	5.6e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	2.5e-05	5.43e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—TGFB1—idiopathic pulmonary fibrosis	2.37e-05	5.15e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—TGFB1—idiopathic pulmonary fibrosis	2.1e-05	4.56e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	2.03e-05	4.4e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	1.9e-05	4.12e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	1.66e-05	3.61e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	1.47e-05	3.19e-05	CbGpPWpGaD
